Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Cancer has long been one of the most persistent and deadly diseases, and with its ability to evolve, resist treatment, and spread relentlessly, it has left scientists grappling for solutions. Yet, ...

First, let’s take a look at the private biotech investments in January 2025, breaking them down by value, location, funding type, and therapeutic subsector. The first month of 2025 saw U.K.-based ...

Today, Akribion Therapeutics, a German biotech company announced its €8 million ($8.2 million) seed round. Akribion Therapeutics is working on G-dase E, a programmable nuclease designed to selectively ...